Manuela Silginer

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Ana Marcu, Leon Bichmann, Lèon Kuchenbecker et al. · Journal for ImmunoTherapy of Cancer · 2021 · 247 citations · Full text

Life Sciences, Immunology, Oncology +17

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells

Caroline Happold, Patrick Roth, Wolfgang Wick et al. · Journal of Neurochemistry · 2012 · 142 citations

Medicine, Molecular Biology, Oncology +17

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Emanuele Puca, Manuela Silginer, Teresa Hemmerle et al. · Science Translational Medicine · 2020 · 134 citations

Medicine, Immunology, Oncology +14

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma

Hannah Schneider, Manuela Silginer, Alexander Steinle et al. · Clinical Cancer Research · 2017 · 115 citations

Medicine, Immunology, Oncology +17

Biological activity of tumor-treating fields in preclinical glioma models

Manuela Silginer, Michael Weller, Roger Stupp et al. · Cell Death and Disease · 2017 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17